Improved Recovery by Iron Following Surgery With Blood Loss, the IRIS-trial

A phase 3 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 338 participants.

Also called NCT05744219

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; quadruple masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 338 participants (planned count) (from the registry)
Sponsor
Jon Unosson (from the registry)
Registry
  • NCT NCT05744219
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Sweden (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT05744219. Randomized; quadruple masking; primary purpose treatment. Start 2024-09-04 (actual); primary completion 2027-12-31 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Improved Recovery by Iron Following Surgery With Blood Loss, the IRIS-trial
Acronym
IRIS
Condition
Surgery
Condition
Liver Metastases
Condition
Liver Cancer
Condition
Pancreas Cancer
Condition
Aortic Aneurysm
Intervention (Drug)
Ferric carboxymaltose
Intervention (Drug)
Placebo
Lead sponsor
Jon Unosson (class: other)

Record details

Record id
cardio:ct-nct05744219
Content hash
891d761656caec89cccaaa72690b021a34bec393e9c02c6df513f769b80c51f3